BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15218323)

  • 21. Schip1 is a novel podocyte foot process protein that mediates actin cytoskeleton rearrangements and forms a complex with Nherf2 and ezrin.
    Perisic L; Rodriguez PQ; Hultenby K; Sun Y; Lal M; Betsholtz C; Uhlén M; Wernerson A; Hedin U; Pikkarainen T; Tryggvason K; Patrakka J
    PLoS One; 2015; 10(3):e0122067. PubMed ID: 25807495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells.
    Shimizu S; Tahara M; Ogata S; Hashimoto K; Morishige K; Tasaka K; Murata Y
    Mol Hum Reprod; 2007 Mar; 13(3):181-7. PubMed ID: 17227815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat.
    Sung JK; Miao L; Calvert JW; Huang L; Louis Harkey H; Zhang JH
    Brain Res; 2003 Jan; 959(1):29-38. PubMed ID: 12480155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of the effects of Y-27632.
    Darenfed H; Dayanandan B; Zhang T; Hsieh SH; Fournier AE; Mandato CA
    Cell Motil Cytoskeleton; 2007 Feb; 64(2):97-109. PubMed ID: 17009325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cofilin phosphorylation in glomerular podocytes by testis specific kinase 1 (TESK1).
    Wang L; Buckley AF; Spurney RF
    Sci Rep; 2018 Aug; 8(1):12286. PubMed ID: 30115939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rho kinase inhibitors block activation of pancreatic stellate cells.
    Masamune A; Kikuta K; Satoh M; Satoh K; Shimosegawa T
    Br J Pharmacol; 2003 Dec; 140(7):1292-302. PubMed ID: 14581180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actin and microtubule regulation of trans-Golgi network architecture, and copper-dependent protein transport to the cell surface.
    Cobbold C; Coventry J; Ponnambalam S; Monaco AP
    Mol Membr Biol; 2004; 21(1):59-66. PubMed ID: 14668139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Rho-kinase induces alphaB-crystallin expression in lens epithelial cells.
    Khurana RN; Maddala RL; Shimokawa H; Samuel Zigler J; Epstein DL; Vasantha Rao P
    Biochem Biophys Res Commun; 2002 Jun; 294(5):981-7. PubMed ID: 12074573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization.
    Patel K; Harding P; Haney LB; Glass WF
    J Cell Physiol; 2003 Jun; 195(3):435-45. PubMed ID: 12704653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.
    Wang S; Chen C; Su K; Zha D; Liang W; Hillebrands JL; Goor Hv; Ding G
    Ren Fail; 2016; 38(2):268-75. PubMed ID: 26652313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
    Maekawa M; Ishizaki T; Boku S; Watanabe N; Fujita A; Iwamatsu A; Obinata T; Ohashi K; Mizuno K; Narumiya S
    Science; 1999 Aug; 285(5429):895-8. PubMed ID: 10436159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression.
    Witteck A; Yao Y; Fechir M; Förstermann U; Kleinert H
    Exp Cell Res; 2003 Jul; 287(1):106-15. PubMed ID: 12799187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.
    Ransom RF; Lam NG; Hallett MA; Atkinson SJ; Smoyer WE
    Kidney Int; 2005 Dec; 68(6):2473-83. PubMed ID: 16316324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho GTPase signaling and PTH 3-34, but not PTH 1-34, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells.
    Kazmers NH; Ma SA; Yoshida T; Stern PH
    Bone; 2009 Jul; 45(1):52-60. PubMed ID: 19361585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the process formation; podocytes vs. neurons.
    Kobayashi N
    Microsc Res Tech; 2002 May; 57(4):217-23. PubMed ID: 12012387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation mediated by RhoA requires activity of ROCK kinases.
    Sahai E; Ishizaki T; Narumiya S; Treisman R
    Curr Biol; 1999 Feb; 9(3):136-45. PubMed ID: 10021386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes.
    Chen J; Guerriero E; Sado Y; SundarRaj N
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3662-70. PubMed ID: 19324862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
    Lee HT; Kay EP
    Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants.
    Zhelev DV; Alteraifi AM; Chodniewicz D
    Biophys J; 2004 Jul; 87(1):688-95. PubMed ID: 15240502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.